MorphoSys AG is a biopharmaceutical company founded in 1992. The company is headquartered near Munich, Germany and has a wholly owned subsidiary, MorphoSys US Inc., in Boston MA in the US. Show more

Location: Semmelweisstr. 7, Bayern, 82152, Germany | Website: https://www.morphosys.de/ | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing


Market Cap

0.00

52 Wk Range

$N/A - $N/A

Previous Close

$18.96

Open

$18.96

Volume

N/A

Day Range

$18.96 - $18.96

Enterprise Value

0.00

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

0.00%

Institutional Own.

7.44%

Qtr Updated

03/31/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Tremfya (guselkumab) (IL-23) Details
Psoriatic arthritis, Plaque psoriasis

Approved

Quarterly sales

Monjuvi (Tafasitamab) (CD19) Details
B-cell malignancies, Diffuse large B cell lymphoma, Chronic lymphocytic leukemia, Non-Hodgkin lymphoma, Cancer

Approved

Quarterly sales

Tafasitamab (CD19) Details
Cancer, B-cell malignancies, B-cell lymphoma, Diffuse large B cell lymphoma

Big Mover™

Susp. Mover™

Phase 3

Data readout

Pelabresib (CPI-0610) + ruxolitinib Details
Myelofibrosis, Cancer, Bone marrow cancer

Phase 3

Data readout

Gantenerumab Details
Alzheimer's disease

Phase 3

Update

Phase 2

Update